
Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
Author(s) -
Marcelo O’Higgins,
Juan Iván Barrios,
José D Almirón-Santacruz,
João Maurício Castaldelli-Maia,
Antonio Ventriglio,
Júlio Torales
Publication year - 2021
Publication title -
indian journal of psychiatry/indian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.485
H-Index - 34
eISSN - 1998-3794
pISSN - 0019-5545
DOI - 10.4103/indianjpsychiatry.indianjpsychiatry_172_21
Subject(s) - ivermectin , medicine , antiparasitic agent , adverse effect , psychiatry , onchocerciasis , ataxia , epilepsy , intensive care medicine , pharmacology , veterinary medicine , pathology